Soloxine Tablets for Dogs | 
Soloxine contains synthetic thyroid hormone which is chemically identical to the naturally occurring hormone. The tablets are given once or twice daily every day to dogs affected by hypothyroidism (low natural levels of thyroid hormone). Hypothyroidism is usually associated with skin and coat changes, as well as a tendency to put on weight and lethargy. Soloxine given for life will control these symptoms so that dogs under treatment will live a perfectly normal life.
| | | | Soloxine Tablets for Dogs | 0.1mg Yellow Tablets » Pot of 100
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£4.79
(inc. VAT) | | 0.1mg Yellow Tablets » Pot of 250
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£11.98
(inc. VAT) | | 0.1mg Yellow Tablets » Priced per Tablet
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£0.05
(inc. VAT) | | 0.2mg Orange Tablets » Pot of 100
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£6.92
(inc. VAT) | | 0.2mg Orange Tablets » Pot of 250
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£17.30
(inc. VAT) | | 0.2mg Orange Tablets » Priced per Tablet
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£0.07
(inc. VAT) | | 0.3mg Green Tablets » Pot of 100
• Temporarily out of stock, due back very soon.
• Veterinary prescription from your vet required. (what's this?) |
£8.16
(inc. VAT) | | 0.3mg Green Tablets » Pot of 250
• Temporarily out of stock, due back very soon.
• Veterinary prescription from your vet required. (what's this?) |
£20.39
(inc. VAT) | | 0.3mg Green Tablets » Priced per Tablet
• Temporarily out of stock, due back very soon.
• Veterinary prescription from your vet required. (what's this?) |
£0.08
(inc. VAT) | | 0.5mg White Tablets » Pot of 100
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£11.53
(inc. VAT) | | 0.5mg White Tablets » Pot of 250
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£28.84
(inc. VAT) | | 0.5mg White Tablets » Priced per Tablet
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£0.12
(inc. VAT) | | 0.8mg Blue Tablets » Pot of 100
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£15.41
(inc. VAT) | | 0.8mg Blue Tablets » Pot of 250
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£38.51
(inc. VAT) | | 0.8mg Blue Tablets » Priced per Tablet
• Usually ships in 24 hours, subject to prescription.
• Veterinary prescription from your vet required. (what's this?) |
£0.16
(inc. VAT) | | |
|  | Customers who purchased these items also purchased |   | | Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the face of each tablet, strength in milligrams to the right and the word SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs. L-Thyroxine is a synthetic product chemically identical to the naturally occurring thyroid hormone 'T4'. Its effect is slow in onset, but of long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the response of the patient and laboratory investigations, and should be administered daily. Pharmacokinetic trials demonstrate that once daily dosing gives higher blood levels than dividing the daily dose over the day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is frequently too low, and doses of up to 44 µg/kg bodyweight/day may be required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested by: panting, nervousness, tachycardia, aggressive behaviour, polyuria, polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the face of each tablet, strength in milligrams to the right and the word SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs. L-Thyroxine is a synthetic product chemically identical to the naturally occurring thyroid hormone 'T4'. Its effect is slow in onset, but of long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the response of the patient and laboratory investigations, and should be administered daily. Pharmacokinetic trials demonstrate that once daily dosing gives higher blood levels than dividing the daily dose over the day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is frequently too low, and doses of up to 44 µg/kg bodyweight/day may be required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested by: panting, nervousness, tachycardia, aggressive behaviour, polyuria, polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
Presentation
Small elliptical tablets containing L-Thyroxine Sodium. Scored on the
face of each tablet, strength in milligrams to the right and the word
SOLOXINE on the reverse.
0.1 mg yellow
0.2 mg orange
0.3 mg green
0.5 mg white
0.8 mg blue
Uses
For the long term treatment of thyroid insufficiency in dogs.
L-Thyroxine is a synthetic product chemically identical to the naturally
occurring thyroid hormone 'T4'. Its effect is slow in onset, but of
long duration.
Dosage and administration
The dosage should be adjusted for the individual case based on the
response of the patient and laboratory investigations, and should be
administered daily. Pharmacokinetic trials demonstrate that once daily
dosing gives higher blood levels than dividing the daily dose over the
day.
The commonly prescribed dose is 22 µg/kg bodyweight/day. This is
frequently too low, and doses of up to 44 µg/kg bodyweight/day may be
required.
Appropriate laboratory tests should be conducted to confirm the diagnosis and ensure correct dosage. For oral administration.
Contra-indications, warnings, etc
Do not use in dogs with thyrotoxicosis or uncorrected adrenal insufficiency.
The effects of Thyroxine therapy are slow in being manifested.
Administer with caution to animals with clinically significant heart
disease, hypertension or other complications for which a sharply
increased metabolic rate might prove hazardous.
Chronic overdosage will eventually lead to thyrotoxicosis, manifested
by: panting, nervousness, tachycardia, aggressive behaviour, polyuria,
polydipsia, polyphagia and weight loss.
If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.
Operator warnings: Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the doctor the leaflet.
General precautions: For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal: Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon.
Legal category
POM-V
Packaging Quantities
Hermetically sealed bottles of 250 tablets.
Further information
To be supplied only on veterinary prescription.
Veterinary medicinal product authorised for use in UK and Ireland.
Marketing authorisation number
For each strength:
0.1 mg - Vm 05653/4140
0.2 mg - Vm 05653/4138
0.3 mg - Vm 05653/4137
0.5 mg - Vm 05653/4139
0.8 mg - Vm 05653/4141 | 
